Henderson Molly 4
4 · Phathom Pharmaceuticals, Inc. · Filed Jun 5, 2023
Insider Transaction Report
Form 4
Henderson Molly
CFO and CBO
Transactions
- Sale
Common Stock
2023-06-02$11.41/sh−1,960$22,368→ 68,506 total
Holdings
- 338.86(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2022.
- [F2]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in two transactions at prices 11.41 and 11.5653. The reporting person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.